Cargando…
Effects of chronic low dose rotenone treatment on human microglial cells
BACKGROUND: Exposure to toxins/chemicals is considered to be a significant risk factor in the pathogenesis of Parkinson's disease (PD); one putative chemical is the naturally occurring herbicide rotenone that is now used widely in establishing PD models. We, and others, have shown that chronic...
Autores principales: | Shaikh, Shamim B, Nicholson, Louise FB |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806357/ https://www.ncbi.nlm.nih.gov/pubmed/20042120 http://dx.doi.org/10.1186/1750-1326-4-55 |
Ejemplares similares
-
PACAP and VIP Mitigate Rotenone-Induced Inflammation in BV-2 Microglial Cells
por: Broome, Sarah Thomas, et al.
Publicado: (2022) -
Opening of microglial K(ATP) channels inhibits rotenone-induced neuroinflammation
por: Zhou, Fang, et al.
Publicado: (2008) -
Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson’s disease model
por: Zhang, Dongdong, et al.
Publicado: (2021) -
The effect of low dose amphetamine in rotenone-induced toxicity in a mice model of Parkinson’s disease
por: Abdel-Salam, Omar M.E., et al.
Publicado: (2020) -
Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson’s disease
por: Liu, Hui-Fang, et al.
Publicado: (2017)